Poor sleep is consistently linked to worse cardiometabolic health, and improving sleep may modestly support weight, glycemic, and blood pressure control.
Evidence
This narrative review examined recent studies and meta-analyses on sleep duration, sleep quality, insomnia, , and circadian disruption across cardiometabolic outcomes.
Caveat
Much of the evidence is associative, while intervention trials are described as emerging and producing modest improvements.
Simplified
BACKGROUND: Short or poor-quality sleep can disrupt glucose metabolism, blood pressure regulation, appetite hormones, and inflammatory pathways, potentially accelerating weight gain, atherosclerosis, and insulin resistance. However, this multidimensional role of sleep in cardiometabolic disease prevention and management remains underappreciated. Existing literature has not fully synthesized how various aspects of sleep influence the spectrum of cardiometabolic conditions, nor how improving sleep might confer health benefits.
OBJECTIVE: This narrative review examines epidemiological evidence linking sleep health to cardiometabolic outcomes, elucidates biological mechanisms underlying these associations, and discusses interventions aimed at optimizing sleep for cardiometabolic benefit.
METHODS: We searched and reviewed recent studies and meta-analyses on sleep duration, sleep quality, insomnia, (OSA), and circadian disruption in relation to obesity, , diabetes, cardiovascular diseases, and mortality.
FINDINGS: Abnormal sleep patterns are consistently associated with elevated risks of obesity, type 2 diabetes, hypertension, cardiovascular events, and all-cause mortality. Habitual short sleep predicts higher incidence of metabolic syndrome and type 2 diabetes, while chronic insomnia is linked to 45% greater odds of developing or dying from cardiovascular disease. Conversely, healthy sleep-typically 7-9 hours of regular, high-quality sleep per night-is associated with favorable cardiometabolic profiles and has been added to public health cardiovascular metrics. Mechanistically, inadequate sleep provokes insulin resistance, sympathetic overactivity, hormonal appetite changes, and systemic inflammation, which synergistically promote cardiometabolic disease.
CONCLUSION: Prioritizing healthy sleep habits and treating sleep disorders should become integral to lifestyle medicine for cardiometabolic health. Emerging intervention trials suggest that extending sleep or treating OSA can modestly improve weight control, glycemic regulation, and blood pressure.
Key numbers
45%
Odds Increase for Cardiovascular Disease
Chronic insomnia linked to higher odds of cardiovascular disease.
30%
Short Sleep Duration Risk
People sleeping less than 6 hours have higher diabetes risk.
Full Text
We can’t show the full text here under this license.
